Angiotensin receptor blockers (ARBs), particularly losartan, are associated with a lower risk for incident epilepsy in patients with hypertension and no preexisting stroke or cardiovascular disease ...
Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...
A substudy of the CHARM trial (see Trial Glossary below for expansion of all trial names mentioned in this article) has shown that the angiotensin receptor blocker (ARB) candesartan reduces the risk ...
BARCELONA, Spain—(UPDATED) In patients with Marfan syndrome, both angiotensin receptor blockers (ARBs) as well as beta-blockers reduce the rate of aortic enlargement by roughly half compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results